首页>
外国专利>
Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase
Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase
展开▼
机译:通过医疗相关装置抑制血栓形成的方法,包括用纤溶基质金属蛋白酶处理
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention provides a method of causing the degradation of fibrin(ogen) (i.e., fibrin, fibrinogen, and related substances) by means of a fibrinolytic matrix metalloproteinase, preferably an MMP-3 or MMP-7. The method of the invention can be performed in vitro to provide diagnostic information characterizing fibrin(ogen) and fibrinolytic physiology. The method can also be performed in vivo as a method of thrombolytic therapy in which a fibrinolytic matrix metalloproteinase is administered to a subject to degrade thrombus in situ. The fibrinolytic matrix metalloproteinase can be administered in conjunction with other active agents, preferably with agents having thrombolytic activity to improve thrombolytic and fibrinolytic therapy. The invention further provides compositions containing a fibrinolytic matrix metalloproteinase for the performance of fibrinolytic or thrombolytic procedures. Also provided are kits that include a fibrinolytic matrix metalloproteinase for performing fibrinolytic or thrombolytic procedures.
展开▼